News
Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma ...
Over 60 executives from the European Union Chamber of Commerce in China and Chinese enterprises attended, including CATL, ...
Pakistan’s pharmaceutical sector stands as one of the steadily growing industries within the country’s economy.
Explore more
9h
Zacks Investment Research on MSNRXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?Recursion Pharmaceuticals RXRX and Relay Therapeutics RLAY are pioneering the use of artificial intelligence (AI) in drug ...
11h
Zacks Investment Research on MSNREGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?Investors will focus on profits from asthma drug Dupixent and sales of Eylea HD when biotech giant Regeneron Pharmaceuticals, ...
Over 5 years of treatment in hemophilia B patients, gene therapy research shows sustained factor IX activity and safety.
Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...
Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results